Publications

2024

Canato S*, Sarate R*, Carvalho-Marques S*, Maia Soares R, Song Y, Monteiro-Ferreira S, Vieugué P, Liagre M, Grossi G, Cardoso E, Dubois C, Conway EM, Schenone S, Sanchez-Danes A$, Blanpain C$.Survivin promotes stem cell competence for skin cancer initiation.Cancer Discovery. 2024 Nov 11. doi: 10.1158/2159-8290.CD-24-0263. Online ahead of print.

denotes *co-first authors, $ co-contributing authors

2018

Sanchez-Danes A, Larsimont JC, Liagre M, Munoz-Couselo E, Lapouge G, Brisebarre A, Dubois C, Suppa M, Sukumaran V, Del Marmol V, Tabernero J, Blanpain C. A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy. Nature (2018) 562(7727): 434–438

Debaugnies M*, Sanchez-Danes A*, Rorive S, Raphael M, Liagre M, Parent MA, Brisebarre A, Salmon I, Blanpain C. YAP and TAZ are essential for basal and squamous cell carcinoma initiation. EMBO Rep (2018) 19:e45809

 Lescroart F, Wang X, Lin X, Swedlund B, Gargouri S, Sanchez-Danes A, Moignard V, Dubois C, Paulissen C, Kinston S, Gottgens B, Blanpain C. Defining the earliest step of cardiovascular lineage segregation by single-cell RNA-seq. Science (2018) 359(6380):1177-1181

Sanchez-Danes A, Blanpain C. Deciphering the cells of origin of squamous cell carcinomas. Nat Rev Cancer (2018) 18(9):549-561

2017

Sanchez-Danes A, Blanpain C (2017) Maintaining hair follicle stem cell identity in a dish. EMBO J (2017) 36(2):132-134

2016

Sanchez-Danes A*, Hannezo E*, Larsimont JC, Liagre M, Youssef KK, Simons BD, Blanpain C Defining the clonal dynamics leading to mouse skin tumour initiation. Nature (2016) 536(7616):298-303

2015

Larsimont JC, Youssef KK, Sanchez-Danes A, Sukumaran V, Defrance M, Delatte B, Liagre M, Baatsen P, Marine JC, Lippens S, Guerin C, Del Marmol V, Vanderwinden JM, Fuks F, Blanpain C. Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion. Cell Stem Cell (2015) 17(1):60-73 

 Fernández-Santiago R, Carballo-Carbajal I, Castellano G, Torrent R, Richaud Y, Sánchez-Danés A, Vilarrasa-Blasi R, Sánchez-Pla A, Mosquera JL, Soriano J, López-Barneo J, Canals JM, Alberch J, Raya Á, Vila M, Consiglio A, Martín-Subero JI, Ezquerra M, Tolosa E. Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.EMBO Mol Med (2015) 7(12):1529-46

2012

Sánchez-Danés A, Richaud-Patin Y, Carballo-Carbajal I, Jiménez-Delgado S, Caig C, Mora S, Di Guglielmo C, Ezquerra M, Patel B, Giralt A, Canals JM, Memo M, Alberch J, López-Barneo J, Vila M, Cuervo AM, Tolosa E, Consiglio A, Raya A. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.EMBO Mol Med (2012) 4(5):380-95

Sanchez-Danes A, Consiglio A, Richaud Y, Rodriguez-Piza I, Dehay B, Edel M, Bove J, Memo M, Vila M, Raya A, Izpisua Belmonte JC. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum Gene Ther (2012) 23(1):56-69

2010

Raya A, Rodriguez-Piza I, Navarro S, Richaud-Patin Y, Guenechea G, Sanchez-Danes A, Consiglio A, Bueren J, Izpisua Belmonte JC A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells. Nat Protoc (2010) 5(4):647-60

Edel MJ, Boue S, Menchon C, Sanchez-Danes A, Izpisua Belmonte JC. Rem2 GTPase controls proliferation and apoptosis of neurons during embryo development. Cell Cycle (2010) 9(17):3414-22